Potential ecological and human health impacts of antibiotics and antibiotic-resistant bacteria from wastewater treatment plants

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 10, Issue 8, 2007, Pages 559-573

  Kim, Sungpyo ^a   Aga, Diana S ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CAFFEINE; CEFALEXIN; CEFPROZIL; CHLORTETRACYCLINE; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; ERYTHROMYCIN; METRONIDAZOLE; OLAQUINDOX; OXOLINIC ACID; OXYTETRACYCLINE; PENICILLIN G; PSEUDOMONIC ACID; STREPTOMYCIN; SULFADIAZINE; SULFAMETHOXAZOLE; TETRACYCLINE; TIAMULIN; TRIMETHOPRIM; TYLOSIN;

ANTIBIOTIC RESISTANCE; BACTERIUM; CHLORINATION; DATA ANALYSIS; ECOLOGY; EFFLUENT; ENVIRONMENTAL IMPACT; EXTRACTION; HEALTH CARE FACILITY; HEALTH HAZARD; HUMAN; NONHUMAN; POLLUTION; REVIEW; RISK ASSESSMENT; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ECOLOGY; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MONITORING; HUMANS; RISK ASSESSMENT; WATER MICROBIOLOGY; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION;

EID: 36749045298     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/15287390600975137     Document Type: Review

References (68)

1. Ayscough, N. J., Fawell, J., Franklin, G., and Young, W. 2000. Review of Human Pharmaceuticals in the Enviroment. Environment Agency of England and Wales, Bristol. UK.
2. Baguer, A. J., Jensen, J., and Krogh, P. H. 2000. Effects of the antibiotics oxytetracycline and tylosin on soil fauna. Chemosphere 40:751-757.
3. Batt, A., Kim, S., and Aga, D. 2007. Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plants with varying designs and operations. Chemosphere. 68:428-435.
4. Campos, J. L., Garrido, J. M., Mendez, R., and Lema, J. M. 2001. Effect of two broad-spectrum antibiotics on activity and stability of continuous nitrifying system. Appl. Biochem. Biotechnol. 95:1-10.
5. Carballa, M., Omil, F., Lema, J. M., L1ompart, M., Garcia-Jares., C., Rodriguez, I., Gomez, M., and Ternes, T. 2004. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res. 38:2918-2926.
6. Chander, Y., Kumar, K., Goyal, S. M., and Gupta, S. C. 2005. Antibacterial activity of soil-bound antibiotics. J. Environ. Qual. 34:1952-1957.
7. Chopra, I., and Roberts, M. 2001. Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. R. 65:232-260.
8. Christensen, F. M. 1998. Pharmaceuticals in the environment - A human risk?, Regul. Toxicol. Pharmacol. 28:212-221.
9. Clara, M., Strenn, B., Gans, O., Martinez, E., Kreuzinger, N., and Kroiss, H. 2005. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 39:4797-4807.
10. Desbrow, C., Routledge, E. J., Brighty, G. C., Sumpter, J. P., and Waldock, M. 1998. Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environ. Sci. Technol. 32:1549-1558.
11. Diaz-Cruz, M. S., Lopez de Alda, M. J., and Barcelo, D. 2003. Environmental behaviour and analysis of veterinary and human drugs in soils, sediments and sludge. Trends Anal. Chem. 22:340-351.
12. Eichhorn, P., and Aga, D. S. 2004. Identification of photooxygenation product of chlortetracycline in hog lagoons using LC/ESI-ion trap-MS and LC/ESI-time-of-flight-MS. Anal. Chem. 76:6002-6011.
13. Eichhorn, P., Ferguson, P. L., Pérez, S., and Aga, D. S. 2005. Application of ion trap-MS with H/D exchange and QqTOF-MS in the identification of microbial degradates of trimethoprim in nitrifying activated sludge. Anal. Chem. 77:4176-4184.
14. Escher, B. I., and Hermens, J. L. 2002. Modes of action in ecotoxicology: Their role in body burdens, species sensitivity, QSARs, and mixture effects. Environ. Sci. Technol. 36:4201-4217.
15. Food and Drug Administration. 1998. Guidance for industry for the submission of an environmental assessment in human drug applications and supplements. Rockville, MD: Food and Drug Administration, Center for Drug Evaluation and Research.
16. Glassmeyer, S. T., Furlong, E. T., Kolpin, D. W., Cahill, J. D., Zaugg, S. D., Werner, S. L., Meyer, M. T., and Kryak, D. D. 2005. Transport of chemical and microbial compounds from known wastewater discharges: Potential for use as indicators of human fecal contamination. Environ. Sci. Technol. 39:5157-5169.
17. Golet, E. M., Alder, A. C., and Giger, W. 2002. Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt valley Watershed, Switzerland. Environ. Sci. Technol. 36:3645-3651.
18. Golet, E. M., Xifra, I., Siegrist, H., Alder, A. C., and Giger, W. 2003. Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil. Environ. Sci. Technol. 37:3243-3249.
19. Goni-urriza, M., Capdepuy, M., Aprin, C., Raymond, N., Caumette, P., and Quentin, C. 2000. Impact of urban effluent on antibiotic resistance of riverine Enterobacteriaceae and Aeromonas spp. Appl. Environ. Microbiol. 66:125-132.
20. Guardabassi, L., and Dalsgaard, A. 2002. Occurrence and fate of antibiotic resistant bacteria in sewage. Danish EPA Environmental Project Report 722. http://www.mst.dk/udgiv/publications/2002/87-7972-266-0/pdf/87-7972- 267-9.pdf, accessed October 5, 2005
21. Guardabassi, L., Danilo, M. A., Wong, L. F., and Dalsgaard, A. 2002. The effect of tertiary wastewater treatment on the prevalence of antimicrobial resistant bacteria. Water Res. 36:1955-1964.
22. Halling-Sørensen, B. 2000. Algal toxicity of antibacterial agents used in intensive farming. Chemosphere 40:731-739.
23. Halling-Sørensen, B. 2001. Inhibition of aerobic growth and nitrification of bacteria in sewage sludge by antibacterial agents. Arch. Environ. Contam. Toxicol. 40:451-460.
24. Halling-Sørensen, B., Nors Nielsen, S., Lanzky, P. F., Ingerslev, F., Holten Lützhøft, H. C., and Jorgensen, S. E. 1998. Occurrence, fate and effects of pharmaceutical substances in the environment-A review. Chemosphere 36:357-393.
25. Hamilton, A. J., Stagnitti, F., Boland, A. M., and Premier, R. 2005. Quantitative microbial risk assessment modelling for the use of reclaimed water in irrigated horticulture. In Environmental health risk III, eds. C. A. Brebbia, V. Popov, and D. Fayzieva, pp. 7181-7191. Transactions on Biomedicine and Health series, vol. 9. Wessex Institute of Technology, UK.
26. Hirsch, R., Ternes, T., Haberer, K., and Kratz, K. L. 1999. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 225:109-118.
27. Ingerslev, F., and Halling-Sørensen, B. 2000. Biodegradability properties of sulfonamides in activated sludge. Environ. Toxicol. Chem. 19:2467-2473.
28. Isidori, M., Nardelli, A., Parrella, A., Pascarella, L., Previtera, L. 2006. A multispecies study to assess the toxic and genotoxic effect of pharmaceuticals: Furosemide and its photoproduct. Chemosphere. 63:785-793.
29. Iwane, T., Urase, T., and Yamamoto, K. 2001. Possible impact of treated wastewater discharge on incidence of antibiotic resistant bacteria in river water. Water Sci. Technol. 43:91-99.
30. Jones, O. A. H., Voulvoulis, N., and Lester, J. N. 2004. Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment. Crit. Rev. Toxicol. 34:335-350.
31. Jones, O. A., Lester, J. N., and Voulvoulis, N. 2005. Pharmaceuticals: A threat to drinking water? Trends Biotechnol. 23:163-167.
32. Joss, A., Anderson, H., Ternes, T., Richle, P. R., and Siegrist, H. 2004. Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions: consequences for plant optimization. Environ. Sci. Technol. 38:3047-3055.
33. Karthikeyan, K. G., and Bleam, W. F. 2003. Occurrence of antibiotics in wastewater effluents and their mobility in soils: a case study for Wisconsin. DNR Project Final Report 169. http://www.dnr.state.wi.us/org/ water/dwg/gw/research/reports/169.pdf, accessed October 5, 2005
34. Kim, S., Eichhorn, P., Jensen J. N., Weber, A. S., and Aga, D. S. 2005. Removal of antibiotics in wastewater: Effect of hydraulic and solid retention times on the fate of tetracycline in the activated sludge process. Environ. Sci. Technol. 39:5816-5823.
35. Kim S., Jensen J. N., Aga, D. S., and Weber, A. S. 2006a. Fate of tetracycline resistant bacteria as a function of activated sludge process organic loading and growth rate. Water Sci. Technol. 55:291-297.
36. Kim S., Jensen J. N., Aga, D. S., and Weber, A. S. 2006b. Tetracycline as a selector for resistant bacteria in activated sludge. Chemosphere. 66:1643-1651.
37. Köhler, A., Hellweg, S., Escher, B. I., and Hungerbühler, K. 2006. Organic pollutant removal versus toxicity reduction in industrial wastewater treatment: The example of wastewater from fluorescent whitening agent production. Environ. Sci. Technol. 40:3395-3401.
38. Kolpin, D. W., Furlong E. T., Meyer, M. T., Thruman, E. M., Zaugg, S. D., Barber, L. B., and Buxton, H. T. 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol. 36:1202-1211.
39. Kruse, H., and Sorum, H. 1994. Transfer of multiple drug resistance plasmids between bacteria of diverse origins in natural microenvironments. Appl. Environ. Microbiol. 60:4015-4021.
40. Kümmerer, K. 2003. Significance of antibiotics in the environment. J. Antimicrob. Chemother. 52:5-7.
41. Löffler, D., and Ternes, T. 2003. Analytical method for the determination of the aminoglycoside gentamicin in hospital wastewater via liquid chromatography-electrospray-tandem mass spectrometry. J. Chromatogr. A 1000:583-588.
42. Macauley, J. J., Qiang, Z., Adams, C., D., Surampalli, R., and Mormile, M. R., 2006. Disinfection of swine wastewater using chlorine, ultraviolet light and ozone. Water Res. 40:2017-2026.
43. Mach, P. A., and Grimes, D. J., 1982. R-plasmid transfer in a wastewater treatment plant. Appl. Environ. Microbiol. 44:1395-1403.
44. Madigan, M. T., Martinko, J. M., and Parker, J. 1997. Brock biology of microorganisms. Englewood Cliffs, NJ: Prentice Hall.
45. McArdell, C. S., Molnar, E., Suter, M. J., and Giger, W. 2003. Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the Glatt valley watershed, Switzerland. Environ. Sci. Technol. 37:5479-5486.
46. Mellon, M., Benbrook, C., and Benbrook, K.L. 2001. Hogging it: Estimates of antimicrobial abuse in livestock. Cambridge, MA: Union of Concerned Scientists.
47. Mezrioui, N., and Baleux, B. 1994. Resistance patterns of E. coli strains isolated from domestic sewage before and after treatment in both aerobic lagoon and activated sludge. Water Res. 28:2399-2406.
48. Morse, A., and Jackson, A. 2003. Fate of a representative pharmaceutical in the environment. Final report to Texas Water Resources Institute. http://twri.tamu.edu/reports/2003/tr227/tr227.pdf, accessed October 5, 2005.
49. Pérez, S., Eichhorn, P., and Aga, D. S. 2005. Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole, and trimethoprim at different stages of sewage treatment. Environ. Toxicol. Chem. 24:1361-1367.
50. Pomati, F., Castiglioni, S., Zuccato, E., Fanelli, R., Vigetti, D., Rossetti, C., and Calamari, D. 2006. Effects of a complex mixture of therapeutic drugs at environmental levels on human embryotic cells. Environ. Sci. Technol. 40:2442-2447.
51. Poté, J., Ceccherini, M. T., Van, V. T., Rosseli, W., Wildi, W., Simonet, P., and Vogel, T.M., 2003. Fate and transport of antibiotic resistance genes in saturated soil columns. Eur. J. Soil Biol. 39:65-71.
52. Routledge, E. J., Sheahan, D., Desbrow, C., Brighty, G. C., Waldock, M., and Sumpter, J. P. 1998. Identification of estrogenic chemicals in STW effluent. 2. In vivo responses in trout and roach. Environ. Sci. Technol. 32:1559-1565.
53. Salyers, A. A., Shoemaker, N. B., Stevens, A. M., and Li, L. Y. 1995. Conjugative transposons: An unusual and diverse set of integrated gene transfer elements. Microbiol. Rev. 59:579-590.
54. Schaub, S. 2004. A risk assessment framework for waterborne pathogens and requirements for producing a complete protocol. Hum. Ecol. Risk Assess. 10:151-158.
55. Schulman, L. J., Sargent, E. V., Naumann, B. D., Faria, E. C., Dolan, D. G., and Wargo, J. P. 2002. A human health risk assessment of pharmaceuticals in the aquatic environment. Hum. Ecol. Risk Assess. 8:657-680.
56. Schwab, B. W., Hayes, E. P., Fiori, J. M., Mastrocco, F. J., Roden, N. M., Cragin, D., Meyerhoff, R. D., D'Aco, V. J., and Anderson, P. D. 2005. Human pharmaceuticals in US surface waters: A human health risk assessment. Regul. Toxicol. Pharmacol. 42:296-312.
57. Schwartz, T., Kohnen, W., Jansen, B., and Obst, U. 2003. Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and drinking water biofilms. FEMS Microbiol. Ecol. 43:325-335.
58. Sedlak, D. L., and Pinkston, K. E. 2001. Factors affecting the concentrations of pharmaceuticals released to the aquatic environment. Universities Council Water Resources 120:56-64.
59. Sedlak, D. L., Gray J. L., and Pinkston, K. E. 2000. Understanding microcontaminants in recycled water. Environ. Sci. Technol. 34:508A-515A.
60. Seelig, B. 2005. Water resource impacts from medicines and other biologically active substances. http://kiowa.colostate.edu/cwis435/ northern_plains_mountains/New/Finished%20bulletin%201278.pdf, accessed October 5, 2005.
61. Stuer-Lauridsen, F., Birkved, M., Hansen, L. P., Holten Lüzhøft, H.-C., and Halling-Sørensen, B. 2000. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 40:783-793.
62. Ternes, T. A., Meisenheimer, M., McDowell, D., Sacher, F., Brauch, H. -J., Haist-Gulde, B., Preuss, G., Wilme, U., and Zulei-Seibert, N. 2002. Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 36:3855-3863.
63. Thibaut, R., Schnell, S., and Porte, C. 2006. The interference of pharmaceuticals with endogenous and xenobiotic metabolizing enzymes in cap liver: An in-vitro study. Environ. Sci. Technol. [DOI: 10.1021/es0607483](available online 7 July 2006, http://pubs.acs.org/cgi-bin/ asap.cgi/esthag/asap/pdf/es0607483.pdf).
64. Vader, J. S., van Ginkel, C. G., Sperling, F. M., de Jong, J., de Boer, W., de Graaf, J. S., van der Most, M., and Stokman, P. G. 2000. Degradation of ethinyl estradiol by nitrifying activated sludge. Chemosphere 41:1239-1243.
65. van Ginneken, M., and Oron, G. 2000. Risk assessment of consuming agricultural products irrigated with reclaimed wastewater: An exposure model. Water Resource Res. 36:2691-2699.
66. Walia, S. K., Kaiser, A., Parkash, M., and Chaundhry, G. R. 2004. Self-transmissible antibiotic resistance to ampicillin, streptomycin, and tetracycline found in Escherichia coli isolated from contaminated drinking water. J. Environ. Sci. Health A Toxic/Hazard. Subst. Environ. Eng. 39:651-662.
67. Webb, S., Ternes, T., Gibert, M., and Olejniczak, K.2003. Indirect human exposure to pharmaceuticals via drinking water, Toxicol. Lett. 142:157-167.
68. Wilson, B. A., Smith, V. H., deNoyelles, F., Jr., and Larive, C. K. 2003. Effects of three pharmaceutical and personal care products on natural freshwater algal assemblages. Environ. Sci. Technol. 37:1713-1719.